Skip to main content
LMRI logo

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Price & Analysis

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) — MoonshotScore 33/100 (Weak band), calculated Nov 18, 2026. Price $14.26 (+1.42%), as of the Nov 20, 2026 trading session; market cap $1.37B.

Educational signal · not a buy or sell recommendation · How to read this

$14.26 +$0.20 (+1.42%) Market Cap $1.37B

Lumexa Imaging Holdings, Inc. Common Stock · LMRI · NASDAQ

Lumexa Imaging Holdings, Inc. operates diagnostic imaging centers in the United States, providing a range of outpatient medical imaging services. The company offers MRI, CT, PET, X-ray, ultrasound, and mammography services.

Price as of Nov 20, 2026

Key Statistics

33 of 100

MoonshotScore v2 · Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

Weak
Business Quality Solid (60)
Financial Safety Fragile (18)
Valuation Fair (60)
Growth Durability Growing (72)
Momentum Surging (93)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Durable growth, but a fragile balance sheet. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Solid; Financial Safety: Fragile; Valuation: Fair; Growth Durability: Growing; Momentum: Surging.

  • quarterly revenue $272M (Q3 FY2026, quarter ended Sep 30, 2026)
  • EPS beat 3 of the last 5 reports
  • Altman Z 0.97 · Piotroski F 6

Holding back: balance-sheet strain

Helping: durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for LMRI (58 recorded, newest six shown)
RecordedScoreBand
34Weak
33Weak
33Weak
33Weak
33Weak
33Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$14.26
Change on the day+1.42%
52-week range$6.45 – $19.45
Market capitalisation$1.37B—
Shares traded on the day442.4K

Price & events

Other perspectives

Council score for Lumexa Imaging Holdings, Inc. Common Stock (LMRI): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Negative
Valuation Moderate
Growth Durability Moderate
Momentum Strong

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Sep 7, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Fairly Valued
Profit Margin Weak
Debt/Equity Negative
ROE Negative
Gross Margin Weak

Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Apr 29, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Lumexa Imaging Holdings, Inc. Common Stock (LMRI), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is listed on NASDAQ. It employs 5,000 people and is led by Caitlin Zulla. In Q3 FY2026 it reported revenue of $272M and net income of $7M. The market values it at $1.37B.

2 · Latest results

What do the latest results show for Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $272M. Against analyst estimates the company has EPS beat 3 of the last 5 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$272M$7M$0.07 (diluted)
Q2 FY2026$264M$3M$0.03 (diluted)
Q1 FY2026$253M$2M$0.02 (diluted)
Q4 FY2025$268M-$29M-$0.38 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?

Short answer · as of

The MoonshotScore pillars rate durable growth, positive momentum as strengths. What is holding it back is balance-sheet strain. The distress and quality screens read Altman Z 0.97 · Piotroski F 6. Trailing ratios: ROE -2.8% · ROA -0.9% · current ratio 1.52 · earnings yield -1.2% · free-cash-flow yield 3.8%.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of 0.97 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-2.8%) — the business is not currently generating profit on shareholder capital.
4 · What to check next?

What should you watch next at Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?

Short answer · as of

The stored analyst-target capture is expired, so a current target watchpoint is unavailable.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.
  • No insider Form 4 transaction falls inside the window this page reads.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Lumexa Imaging Holdings, Inc. Common Stock compare with its peers?

Short answer

Lumexa Imaging Holdings, Inc. Common Stock's score ranks tied for 12th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Inspire Medical Systems, Inc. (INSP) Same industry, near in market value$55.10 Nov 20, 2026$1.60B94 5-pillar Nov 18, 2026
IRadimed Corporation (IRMD) Same industry, near in market value$81.02 Nov 20, 2026$1.04B94 5-pillar Nov 18, 2026
InMode Ltd. (INMD) Same industry, near in market value$12.42 Nov 20, 2026$715M92 5-pillar Nov 18, 2026
UFP Technologies, Inc. (UFPT) Same industry, near in market value$290.85 Nov 20, 2026$2.25B87 5-pillar Nov 18, 2026
CONMED Corporation (CNMD) Same industry, near in market value$46.56 Nov 20, 2026$1.39B79 5-pillar Nov 18, 2026
Integra LifeSciences Holdings Corporation (IART) Same industry, near in market value$13.25 Nov 20, 2026$1.03B68 5-pillar Nov 18, 2026
Varex Imaging Corporation (VREX) Same industry, near in market value$18.10 Nov 20, 2026$769M62 5-pillar Nov 18, 2026
SI-BONE, Inc. (SIBN) Same industry, near in market value$23.73 Nov 20, 2026$1.07B39 5-pillar Nov 18, 2026
OrthoPediatrics Corp. (KIDS) Same industry, near in market value$31.74 Nov 20, 2026$829M37 5-pillar Nov 18, 2026
Establishment Labs Holdings Inc. (ESTA) Same industry, near in market value$69.14 Nov 20, 2026$2.06B35 5-pillar Nov 18, 2026
Artivion Inc. (AORT) Same industry, near in market value$18.16 Nov 20, 2026$886M34 5-pillar Nov 18, 2026
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) — this page$14.26$1.37B33
Cytek Biosciences, Inc. (CTKB) Same industry, near in market value$6.12 Nov 20, 2026$800M33 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
$13.00 – $19.00
Last captured analyst target (expired, captured Nov 18, 2026)
$16.80
Last captured median analyst target (expired, captured Nov 18, 2026)
$18.00

Historical target record · Captured · Capture expired; not a current watchpoint.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held LMRI in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported LMRI in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?

Read these with our analysis →

Common Questions About LMRI

These answers are editorial: 1 of these 9 answers is drawn from the LMRI research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for LMRI?

LMRI carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is LMRI a good stock to buy?

Stock Expert AI does not rate LMRI buy, sell or hold. Lumexa Imaging Holdings, Inc. Common Stock carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the LMRI stock price today?

The last price recorded for Lumexa Imaging Holdings, Inc. Common Stock (LMRI), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the LMRI price target?

The last analyst consensus price target we captured for Lumexa Imaging Holdings, Inc. Common Stock (LMRI), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

What does Lumexa Imaging Holdings, Inc. do?

Lumexa Imaging Holdings, Inc. operates a network of diagnostic imaging centers across the United States, providing a comprehensive range of outpatient medical imaging services.

What are the key factors to evaluate for LMRI?

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) holds a MoonshotScore in the low range. Established network of diagnostic imaging centers provides a stable revenue base. Not financial advice.

How frequently does LMRI data refresh on this page?

LMRI's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven LMRI's recent stock price performance?

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive range of imaging services. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider LMRI overvalued or undervalued right now?

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 18 figures on this page — 10 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.